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Papillomaviruses use rare codons with respect to the host. The reasons for this are incompletely understood
but among the hypotheses is the concept that rare codons result in low protein production and this allows
the virus to escape immune surveillance. We changed rare codons in the oncogenes E6 and E7 of the
cottontail rabbit papillomavirus to make them more mammalian-like and tested the mutant genomes in
our in vivo animal model. While the amino acid sequences of the proteins remained unchanged, the
oncogenic potential of some of the altered genomes increased dramatically. In addition, increased
immunogenicity, as measured by spontaneous regression, was observed as the numbers of codon changes
increased. This work suggests that codon usage may modify protein production in ways that inﬂuence
disease outcome and that evaluation of synonymous codons should be included in the analysis of genetic
variants of infectious agents and their association with disease.
& 2013 Elsevier Inc. All rights reserved.Background
Papillomaviruses are double stranded non-enveloped DNA
tumor viruses with genomes of about 8 Kb. These viruses infect
mucosal and cutaneous tissues of many animal species and
demonstrate high tissue and species speciﬁcities. Papilloma-
viruses infect the basal layer of the epidermis via micro abrasions
in the skin and mucosa and are maintained at low copy number
until the cells differentiate. At that point, copy number increases
markedly and virion production ensues. The pathogens are
dependent upon cellular differentiation for the completion of
the life cycle and therefore the full life cycle is ideally studied in
the intact host. The rabbit papillomavirus model is one of the best
in vivo models for studying the course of papillomavirus diseasell rights reserved.
earch Foundation,
, Hershey PA 17033, USA.
b11@psu.edu (L.R. Budgeon),from initiation of infection to malignant progression. For a review
of the molecular biology of papillomaviruses see (Doorbar, 2006).
Papillomaviruses use rare codons relative to their hosts(Zhao et al.,
1999, 2003). The reasons for this bias are not well understood but it
has been postulated that this is a mechanism to allow the virus to
escape immune surveillance (Tindle, 2002). This theory suggests that
the rare codons employed by the virus insure a low rate of translation
resulting in protein levels sufﬁcient to carry out viral functions but
insufﬁcient to trigger a signiﬁcant immune response. In recent years,
codon modiﬁcations that make the codons of many different genes
more host-like have resulted in increased protein production in vitro
(Mossadegh et al., 2004; Mechold et al., 2005; Gao et al., 2003). Thus,
in vitro studies support the hypothesis that papillomaviruses may use
rare codons to limit protein production.
A second hypothesis is that papillomavirus codon usage may
be tuned to the tRNA proﬁle of the host and, speciﬁcally, to the
cell in which the viral protein needs to be active as well as the
stage of differentiation at which it needs to be expressed (Zhao
et al., 2005; Ding et al., 2010; Gu et al., 2004, 2007). We have
shown that codon usage differs from gene to gene within a
papillomavirus species as well as between a given gene for the
alpha and beta papillomaviruses (Cladel et al., 2010). These
Fig. 1. Codon optimizations in the 50 region of E6 to create E6/15 and E6/17.
Nucleotide changes were introduced into H. CRPV (Genbank accession number
JF303889). Long E6 by site-directed mutagenesis. Changes for E6/15 and E6/17 are
shown. Newly created codons are more commonly used in mammals than are the
original codons. Nucleotides for the mutated portion of E6 are shown.
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proﬁles are related to location and timing of gene expression.
For many years, synonymous codons were thought to be
redundant and were often ignored in the analysis of data. Recent
work, however, has shown that synonymous codon variants may
display marked phenotypic differences (Kallel et al., 2009;
Kimchi-Sarfaty et al., 2007; Capon et al., 2004; Duan et al.,
2003; Nackley et al., 2006; Edwards et al., 2012; Bible et al.,
2000; Hamano et al., 2007; Mueller et al., 2006; Burns et al.,
2006). The study of synonymous codon usage in both prokaryotes
and eukaryotes is now an active ﬁeld of investigation and has
been correlated with (1) control of rate of translation (the speed
at which translation occurs) (Lavner and Kotlar, 2005; Lemm and
Ross, 2002) (2) nucleosome positioning (Segal et al., 2006) (3)
tissue speciﬁcity requirements (Zhou et al., 1999; Gu et al., 2004,
2007) (4) mRNA stability and secondary structure (Capon et al.,
2004; Duan et al., 2003; Chamary and Hurst, 2005) (5) mRNA
copy number (Akashi, 2003; Sharp and Cowe, 1991), (6) splicing
(Fairbrother et al., 2004; Chamary et al., 2006; Parmley and Hurst,
2007), (7) selection for translational efﬁciency (the rate at which
properly folded protein is achieved) (Gingold and Pilpel, 2011;
Chamary and Hurst, 2005), (8) selection for proper protein folding
(Cortazzo et al., 2002), (9) regulation by microRNA (Zheng and
Wang, 2011) and (10) selection for translational kinetics { ‘‘yis
based on the right combination of codons( common and rare) that
allows a regulated ribosome trafﬁc rate ensuring the proper
protein folding’’} (Aragones et al., 2010). In a recent study, Chen
et al. (2010) concluded that synonymous SNPs (sSNPS) are just as
likely as non-synonymous SNPS (nsSNPs) to be involved in
disease mechanisms.
The E7 gene is one of the two major oncogenes of the cotton-
tail rabbit papillomavirus (CRPV) and has been found to be poorly
immunogenic (Han et al., 1999). Since E7 is expressed in nearly all
papillomavirus-associated malignancies, it is an important immu-
nological target for therapeutic vaccines. In earlier work, our
laboratory undertook the codon ‘‘optimization’’ of the CRPV
oncogene E7 in the context of the wild type genome in an attempt
to increase the protein production of this gene in vivo. The term
‘‘optimization’’ is deﬁned in this context as the replacement of
viral codons rarely used by the host with those commonly used
by the host. We hypothesized that changing some of the codons
to be more host-like would improve protein production and allow
for better targeting of the viral oncoprotein by the immune
system. We found that the codon modiﬁcations in the E7 gene
resulted in both altered immune responses and papilloma growth
rates relative to those found with the wild type virus (Cladel et al.,
2008b). Enhanced protein production was noted following tran-
sient transfection of codon-modiﬁed E7 expression constructs.
mRNA amounts and stabilities also increased under these condi-
tions. To our knowledge this was the ﬁrst use of codon optimiza-
tion in the context of a pathogen to study host/pathogen
interactions in vivo.
In the current study, the scope of our efforts was expanded to
include the second CRPV oncogene, E6. E6 and E7 have been
reported to work synergistically both in rabbit (Ganzenmueller
et al., 2008) and in human (Moody and Laimins, 2010) papillo-
maviruses. We report here that codon optimizations in both
oncogenes resulted in phenotypic changes, some of which were
dramatic. Among these changes were (1) altered growth rates, (2)
greatly reduced times to cancer, (3) increased numbers of cancers,
and (4) enhanced immunogenicity. The results are novel and, to
our knowledge, are the ﬁrst to demonstrate an association
between synonymous codons and malignant potential in vivo.
The ﬁndings demonstrate the utility of the CRPV/rabbit model to
elucidate the functions of synonymous codons at the same time
that the biological complexities of the virus are being unraveled.Results
CRPV genomes with codon optimizations in the E6 gene showed
phenotypic differences
Data on codon optimizations in the E7 gene were reported in an
earlier paper (Cladel et al., 2008b) and are also shown in Supple-
mentary Fig. S1. CRPV genomes with 15 (E6/15) and 17 (E6/17)
synonymous codon changes in the N terminus of E6 were prepared
for this study (Fig. 1). CRPV has two E6 isoforms: long E6 (LE6) and
short (SE6) (Barbosa and Wettstein, 1988). Long E6 was chosen for
modiﬁcation as we have shown that it is essential for papilloma
formation whereas SE6 is not (Hu et al., 2006). In addition, changes
in short E6 would have involved concomitant changes in over-
lapping E8. All changes present in E6/15 were also present in E6/17.
The changes were introduced within the 149 nucleotides upstream
of the start of the overlapping E8 gene (CRPVnt 323) and down-
stream of the introduced Sac II cloning site (CRPVnt 174). Each
modiﬁed E6 gene was substituted into the wild type Hershey CRPV
(H. CRPV) backbone and the genomes were tested for function on a
small number of rabbit skin sites. Both genomes produced papillo-
mas. E6/15 grew at wild type rate whereas E6/17 grew more slowly
(Po0.005, unpaired student’s t test, Fig. 2A and B).
CRPV genomes with synonymous codon changes in both E6 and E7
displayed different phenotypes depending upon the combination
of modiﬁed genes
Outbred New Zealand White (NZW) rabbits were used for all
experiments. Growth curves for papillomas from CRPV with 14
changes in E7 and 15 changes in E6 (E7/14-E6/15) relative to wild
type are shown in Fig. 3. E7/14-E6/15 papillomas grew statistically
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E7/18-E6/17 induced papillomas that grew faster than wild type
(Po0.05, data not shown). CRPV E7/22-E6/17 papillomas followed
three different courses: (1) progressive growth over time in four
animals, (2) markedly reduced, but persistent, growth relative toFig. 3. Papillomas generated from E7/14-E6/15 grew statistically faster than papilloma
and E7/14-E6/15 at two sites for a total of twelve sites per genome. E7/14-E6/15 grew st
Student’s t test).
Fig. 2. (A,B) Papillomas generated from E6/15 and E6/17 grew at statistically
different rates. Six animals were infected with wild type H. CRPV, H. CRPV with 15
codon changes in E6 (E6/15) and H. CRPV with 17 changes in E6 (E6/17) at four
sites each for a total of 24 sites per genome. E6/15 papillomas grew at wild type
rate and E6/17 papillomas grew more slowly than wild type (Po0.005 Student’s
t test).wild type in another four animals, and (3) wild type growth
followed by rapid regression in the remaining three animals
(Fig. 4A–C). In the third group, CRPV E7/22-E6/17 papillomas
provoked immune responses that inﬂuenced the behavior of
papillomas derived from the other genomes growing on the same
rabbits. All papillomas on the regressing animals regressed includ-
ing those initiated by wild type CRPV DNA (Fig. 4C). E7/40-E6/17
was the genome with the greatest number of codon alterations.
This genome generated papillomas at only a subset of sites and
lesions were small. Detailed analysis of E7/40-E6/17 papillomas
remains to be done due to inconsistent and slow growth rates.
These data together demonstrated the inﬂuence of synonymous
codons on progression and regression of papillomas and conﬁrmed
our earlier work (Cladel et al., 2008b) that the immune system was
responsive to synonymous changes in the codons.
Early cancers were detected in animals with papillomas from codon-
optimized genomes
Forty nine animals were observed bearing papillomas initiated
by both wild type (wt) Hershey CRPV and at least one of the codon-
optimized genomes. By 10 months post infection, 45% of these
animals had developed at least one carcinoma originating from one
of the codon-optimized genomes. None of the papillomas initiated
by wt CRPV on the same animals became malignant during this
time span [P¼1.1108, Fisher’s exact test, two tailed.
E7/14-E6/15 genomes produced 28 carcinomas out of 98 sites;
cancers were detected from an early time point of 5 months (8
sites) to a late time point of 10 months (6 sites). There were no
cancers at the 34 wild type sites on these rabbits (P¼1.3104,
Fisher’s exact test, two tailed, Supplementary Table 1). A total of
17 animals were infected with E7/14-E6/15 and cancers were
detected in 11 (65%) of these animals. Some regressions or partial
regressions were noted in the remaining animals.
E7/18-E6/15 genomes produced 12 carcinomas out of 39 sites;
cancers were detected from an early time point of 3 months (1 site)
to a late time point of 13 months (1 site). There were no wild type
cancers at the 38 sites during this time period (P¼1.8104,s from wild type CRPV. Six animals were infected with wild type CRPV at two sites
atistically larger papillomas relative to wild type in outbred NZW rabbits (Po0.01,
Fig. 4. (A–C) Papillomas generated from E7/22-E6/17 displayed three different
growth proﬁles. Twelve animals were infected at two sites each with wild type
CRPV and with E7/22-E6/17 CRPV. One animal died before completion of the
study. Papilloma growth displayed three different phenotypes. (A) Papillomas on
ﬁve animals grew steadily. There was no signiﬁcant difference between wild
type and E7/22-E6/17 growth rates at early time points in these animals;
however, at later time points the difference became signiﬁcant (P¼0.01,
Student’s t test). (B) Papillomas on three other animals grew feebly but
persistently. E7/22-E6/17 papillomas grew statistically more slowly in these
animals relative to wild type (P¼0.002) and statistically more slowly than the
same papillomas in the progressor animals of group A (Po0.001, Student’s t test).
(C) All papillomas on the remaining three animals rapidly regressed, including those
of wild type controls.
Table 1
Time to cancer for all codon-optimized genomes. Constructs were tested in the
following numbers of animals: E7/8-E6/15, n¼2; .E7/14-E6/15, n¼17; E7/18-E6/15,
n¼18; E7/18-E6/17. n¼22; E7/22-E6/17, n¼11; E6/15. n¼14; E7/14, n¼4; E7/18,
n¼6. Each number in a box represents the number of cancers for a given genome(y
axis) at a given month(x axis). Wild type cancers were from historical records as no
wild type cancers were detected during the studies with the codon-optimized
genomes.
E7/8-E6/15 2 2
E7/14-E6/15 8 9 2 1 2 6




1 1 2 2
E7/14
2 2 1 3 1
E7/18
2
WILD TYPE 2 1 1
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
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animals were infected with E7/18-E6/15 and cancers were
detected in 9 (50%) of these animals. Some regressions or partial
regressions were noted in the remaining animals.
Genomes E7/14, E6/15, E7/18-E6/17, E7/22-E6/17, and E7/17 all
yielded early cancers although they were not studied in sufﬁcient
numbers to determine signiﬁcance. Table 1 summarizes the cancer
data for all of the genomes in this study. It is interesting to note
that the genomes with the most codon changes progressed to
cancer more rapidly. Thus cancers generated by both E7/18-E6/17
and E7/22-E6/17 occurred as early as 3 months post infection.
These genomes will need to be tested in larger numbers to see if
this trend holds up statistically.Taken together, these data demonstrate the impact of synon-
ymous codon modiﬁcations in the oncogenes of CRPV on the time
of cancer development.Reduction in growth rate and/or regressions were seen in animals
bearing papillomas from codon-optimized genomes
Regressions of papillomas generated by wild type Hershey
CRPV are rare. Regressions of lesions induced by the ‘‘regressor’’
strain, isolated both in this laboratory (‘‘CRPVr’’) and at the Pasteur
Institute (‘‘CRPVb’’, Genbank accession number AJ243287) are
common and occur early, within 8 weeks of papilloma outgrowth
(Salmon et al., 1997; Hu et al., 2002). Clear evidence for host
immunological mechanisms accounting for this regression is the
observation that treatment with cyclosporine A results in persistent
growth of papillomas initiated by the regressive strain of virus (Hu
et al., 2005). In the animals bearing papillomas generated by our
codon modiﬁed genomes, reduction in growth or outright regres-
sion was frequently observed. This regression was most clearly seen
in some animals bearing papillomas generated by E7/22-E6/17, as
noted above (Fig. 4B and C) but was also observed with some of the
other genomes. A total of 15 out of 49 animals experienced total
regression or reduction in growth of their papillomas. In other
unrelated experiments ongoing at the same time in our laboratory,
no regressions were observed with wild type papillomas (n¼53,
P¼4.5105.Chi-square with Yates Correction).Two cancers that developed from papillomas from codon-altered
genomes also displayed regression tendencies
Two cancers from papillomas generated by codon-altered
genomes regressed and then later returned as aggressive cancers
(data not shown).Q PCR on one of the samples showed abundant
copies of CRPV DNA. This observation of cancer regression/
resurgence has not been made in this laboratory with cancers
derived from wild type H. CRPV nor has it been reported from
other laboratories. Only two sites displayed this phenomenon, but
it is worth noting that many of the sites that developed later
(rather than earlier) cancers also displayed reduction in the
growth of papillomas. (See supplementary Tables 1 and 2). These
observations would suggest that in such lesions there was
competition between immunological and proliferative responses
with the proliferative response generally gaining the advantage.
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DNA was extracted from selected papilloma biopsies and the
E6 and E7 genes were ampliﬁed by PCR; the PCR products were
subsequently sequenced. All modiﬁcations were maintained in
the papilloma DNA. No other changes were noted.Table 3Codon optimization did not inﬂuence mRNA levels in papillomas
generated by codon-optimized genomes
Quantitative RT-PCR was used to determine baseline mRNA
expression of wild type E6 and E7 in papillomas at week 8.5. We
then analyzed mRNA levels from papillomas containing wild type
E6 and E7, E7/14-E6/15 and E7/18-E6/15. There were six animals
in this experiment and each animal was infected at two sites each
with wt CRPV, E7/14-E6/15 and E7/18-E6/15. All papillomas
yielded about the same amount of E7 mRNA at 8.5 weeks post
infection. Likewise, wt E6 and E6/15 in both E7/14-E6/15 and
E7/18-E6/15 yielded the same amount of E6 mRNA (Fig. 5). Thus,Fig. 5. Wild type and codon optimized E6 and E7 mRNA levels at 8.5 weeks post
infection were not signiﬁcantly different. Six animals were infected at two sites
each with wild type CRPV, E7/14-E6/15 CRPV and E7/18-E6/15 CRPV. Wild type
E7, E7/14, and E7/18 were all expressed at about the same level at 8.5 weeks post
infection. Wild type E6 and E6/15 levels were the same at this time point. Thus
codon optimization did not inﬂuence mRNA levels. E7 mRNA levels were
statistically higher than E6 mRNA levels. Po0.0007, Student’s t test.
Table 2
Gibb’s free energy (dG, kcal/mol) as computed by mfold for wild type and codon
optimized oncogenes. The Zuker mfold program (http://www.bioinfo.rpi.edu/
applications/mfold), version 3.5, was used to fold mRNAs of the mutated portion
of E6 5’ of the E8 ATG and the entire E7. All optimized genes, with the exception of
E7/18, were predicted to have higher stabilities (lower free energies) than the
corresponding wild type gene.
Gibb’s free energy (dG in kcal/mol) for wild type and codon optimized
oncogenes
GENOME dG, kcal/mol, calculated
by mfold version 3.5
E6, WILD TYPE, 5’ of E8 start 29.96
E6/15 5’ of E8 start 47.66
E6/17 5’ of E8 start 57.70




E7/40 90.15codon optimizations did not inﬂuence message in papillomas at
8.5 weeks post infection. The 8.5 week time point was chosen
because at this point, papillomas have had time to develop
substantial mass but have not yet progressed to cancer. Time-
dependent variations in mRNA levels may occur.M-Fold plots of codon-modiﬁed genes showed increased mRNA
stabilities in all cases
mRNA stability has been associated with gene expression (Wei
et al., 2009; Edwards et al., 2012). We wanted to test whether the
codon changes made to the E6 and E7 oncogenes would be
predicted to alter mRNA stabilities. The Zuker M-Fold program
(Zuker, 2003) was used to fold each full length E7 gene and the 50
portions of the E6 genes in which the codon alterations were
made. Table 4 shows optimal free energies for each mRNA. EachStatistical differences in PHH3 counts per high powered ﬁeld between wild type
(L) and E7/14-E6/15(R) papillomas at time points 2, 3, and 4 were noted. ‘‘n’’
represents the number of ﬁelds counted per site. Where statistical differences
were noted for papillomas from the two genomes, there were always fewer
mitoses in the codon-modiﬁed papillomas relative to wild type. Where signiﬁcant
differences were noted for the same genome at different time points, there were
always lower counts at later time points.
Time point/
genome
2L 2R 3L 3R 4L 4R
2L(n¼83) – P¼0.56 P¼0.01 – P¼0.01 –
2R(n¼148) P¼0.56 – – Po0.001 – Po0.001
3L(n¼104) P¼0.01 – – Po0.001 Po0.001 –
3R(n¼137) – Po0.001 Po0.001 – – P¼0.63
4L(n¼96) P¼0.01 – Po0.001 – – P¼0.02
4R(n¼114) – Po0.001 – P¼0.63 P¼0.02 –
Table 4
E6 synonymous changes and resultant changes in frequency per thousand in
rabbit. Synonymous changes were made to a total of nine different amino acids in
E6 to convert codon usage from rare, as used in rabbit, to common, as used in
rabbit. The codon changes and resultant frequency/1000 codons are shown for
both E6/15 and E6/17.
Transition Frequency of virus codon/1000 in rabbit
relative to frequency of modiﬁed codon/1000
in rabbit
E6/15
Ser TCG4TCC 5.7 /19.4
Gln CAA4CAG 9.2 / 33.0
Leua TTA4CTA 5.3 / 4.9
Ile ATA4ATC 6.1 / 29.7
Leu TTG4CTG 10.9 / 48.8
Gly GGT4GGC 8.8 / 26.7
Ile ATA4ATC 6.1 / 29.7
Leu TTG4CTG 10.9 / 48.9
Leu TTG4CTG 10.9 / 48.9
Ala GCA4GCC 12.7/ 34.2
Thr ACG4ACC 9.1 / 22.0
Leu CTA4CTG 4.9 / 48.9
Ile ATT4ATC 14.3 / 29.7
Val GTA4GTG 4.8 / 33.3
Pro CCG4CCC 8.7 / 20.8
E6/17
Leu CTA4CTG 4.9 / 48.9
Leub CTA4CTG 4.9 / 48.9
Leu TTG4CTG 10.9 / 48.9
a Not actually an optimization but designed to be an intermediate to an
optimized codon in E6/17.
b The result of two nucleotide changes. The ﬁrst, in E6/15 above, is neutral.
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predicted to have enhanced stability (lower dG) over that of the
wild type mRNA. These results show that mRNA stability could be
a factor in the ﬁndings of this study. Note that in our earlier paper
(Cladel et al., 2008b) we showed increased stability of the codon-
modiﬁed E7 mRNA in vitro.
Differences in proliferation markers were detected in a time course
study comparing papillomas from wild type and E7/14-E6/15
infections
Eight rabbits were infected at three left sites with wild type
CRPV and at three right sites with E7/14-E6/15. Measurements of
papillomas were taken weekly. At weeks 5, 10, 15 and 20 post
infection, two rabbits were sacriﬁced and sections of all papillomas
were prepared. H and E analyses and CRPV E7, MCM7, and PHH3
staining were done on all sections except the time point 1(week 5)
sections that were lost due to processor malfunction.
The steady state levels of E7 are low in most papillomas and
have been challenging to detect immunohistochemically.
We were able to detect the protein using our single monoclonal
antibody to CRPV E7 by using antigen retrieval technology and
found the protein to localize to the nucleus (Fig. 6). We were not
able, however, to conﬁrm quantitative differences in protein
production.
MCM7 is a commonly accepted surrogate marker for E7
(Middleton et al., 2003). We therefore stained the time course
sections for MCM7 protein. Over the 5 month period of the study,
the intensities of the staining varied. We found that at time point
2 (10 weeks), codon-modiﬁed sections stained more strongly; at
time point 3 (15 weeks), wild type staining had increased and
codon-modiﬁed staining had decreased; by time point 4 (20
weeks) staining for both wild type and codon modiﬁed papillo-
mas was lower than at the earlier time points (see Fig. 7).
PhosphohistoneH3 (PHH3) is speciﬁcally expressed during
mitosis but not at other points in the cell cycle(Juan et al., 1998;
Crosio et al., 2002). We stained all sections with Rabbit anti-human
PHH3 (Cell Signaling cat# 9701). We expected to see increased
expression of protein in the codon-optimized papillomas based on
their enhanced malignant potential. Instead, we detected a ten-
dency for lower pHH3 positivity in the codon-optimized samples
versus the wild type papillomas except at time point 2. In addition,Fig. 6. CRPV E7 could be detected in the nucleus. Papillomas from wild type and codon-
the E7 protein. E7 localized to the nucleus and appeared to be more pronounced in t
equivocal.in synchrony with the MCM7 observations, we observed decreased
expression over time for both wild type and codon-modiﬁed
papillomas. In this study, we quantitated the PHH3-positive cells
in individual sections from time points 2, 3 and 4 (weeks 10, 15
and 20, respectively) using two different methods—hot spot
analysis (Perry et al., 1997) and counts per high powered ﬁeld
(Coupland et al., 2008). Absolute numbers differed but with both
computational methods, the trends were similar. The data for
counts per high powered ﬁeld are summarized in Table 3 and
graphed in Fig. 8. Fig. 8 also includes a graph of the hot spot
analysis for comparison. Using counts per high power ﬁeld,
we found that codon-modiﬁed papillomas contained statistically
fewer mitotic cells at time points 3 ( Po0.001 ) and 4 (P¼0.02)
(Mann–Whitney rank sum test) relative to wild type. In addition,
over time there was a statistically signiﬁcant reduction in counts
in both codon-modiﬁed and wild type papillomas.
Papillomas generated from codon-optimized genomes contained
a higher copy number of viral genomes
Quantitative PCR was used to determine relative viral DNA copy
numbers in wild type and codon-optimized papillomas. Papillomas
were excised at the time of sacriﬁce of the animals and most were
between 6 and 10 months post infection. Wild type and codon-
modiﬁed papillomas from the same animals were investigated in
the same Q PCR reactions. In a comparison of 26 wild type and 44
codon-optimized papillomas, copy number was higher in the
papillomas from codon-optimized genomes (P¼0.007, unpaired
Student’s t test). Similar results (Fig. 9) were obtained when copy
numbers of wild type (n¼15) and E7/14-E6/15 (n¼22) genomes
from the time course study were compared (P¼0.001).
Dysplastic changes were noted histologically at very early time points
in papillomas generated by codon-optimized genomes
H and E sections from all of the papillomas from the time point
study referenced above were prepared. As noted, in this experi-
ment eight animals were infected with wild type DNA at three
sites on the left back and with E7/14-E6/15 at three sites on the
right back. At intervals of 4–5 weeks starting at week 5, two of the
animals were sacriﬁced and the papillomas were excised. Evalua-
tion of the sections showed rapid development of dysplasia in theoptimized genomes were stained for CRPV E7 using an in house antibody raised to
he codon-optimized sections. However, efforts to quantitate the differences were
Fig. 7. MCM7 staining patterns changed over time. (A) At time point 2, staining of papillomas from E7/14-E6/15 genomes was stronger than wild type. (B) At time point 3,
the reverse was true and there was a reduction in staining of E7/14-E6/15 papillomas relative to time point 2. (C) By time point 4, staining was reduced in papillomas from
both wild type and E7/14-E6/15 genomes.
Fig. 8. PHH3 staining showed signiﬁcantly fewer mitotic ﬁgures in sections of papillomas from the E7/14-E6/15 genome than from the wild type genome at time points
3 and 4. Left, Six sections from each time point for papillomas from both wild type CRPV and E7/14-E6/15 were examined for mitotic ﬁgures. Figures were counted per
20 high powered ﬁeld (Coupland, Campbell, and Damato 1778–85) across the entire sections. Data were entered into Sigmaplot and signiﬁcance was determined by the
Mann–Whitney Rank Sum test. Table 5 shows statistics. Right, Mitotic ﬁgures were counted using Hot Spot analysis (Perry et al., 1997). In both cases, mitotic ﬁgures
declined over time and were lower in papillomas from the codon-optimized genome for time points 3 and 4.
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Fig. 9. DNA copy number was higher in papillomas from codon-optimized genomes relative to wild type genome. (A) DNA copy number was determined by Q PCR
for wild type papillomas (n¼26) and papillomas induced by codon-optimized genomes (n¼48). Ribosomal RNA was used as internal control. Delta Ct values were
entered into SigmaPlot and statistical signiﬁcance was computed by Student’s t test (P¼0.007). (B) The same analysis was done for DNAs from the time course
study (P¼0.001).
Fig. 10. H and E analyses of papillomas at different time points revealed increased dysplasia in papillomas from the E7/14-E6/15 genome as well as more
pronounced immune inﬁltrates. H and E sections were prepared from papillomas from the time course study. Representative sections from time points 2, 3 and
4 are shown. At each time point, the papillomas from codon-modiﬁed genomes were more disordered than the corresponding wild type papillomas as evidenced
by disruption of the basement membrane and invasion into the dermis. Heavy immune inﬁltrates were also seen in the papillomas from E7/14-E6/15 at time
points 3 and 4.
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N.M. Cladel et al. / Virology 438 (2013) 70–8378papillomas; the dysplasia was most marked in papillomas from
codon-modiﬁed genomes. Fig. 10 shows representative wild type
and codon-modiﬁed papillomas at time points 2, 3 and 4.
Discussion
In this study, we have expanded on our earlier work (Cladel
et al., 2008b) to develop a robust animal model for the explora-
tion of synonymous codon usage. This model was designed for
two purposes: (1) to accelerate the appearance of phenotypic
characteristics of the CRPV infection, thereby allowing for more
expedient study of viral pathology and (2) to provide an in vivo
mechanism for evaluating the ﬁndings on synonymous codon
usage arising from the many in silico analyses currently being
conducted. We demonstrate that it is possible to accomplish both
goals simultaneously with this model and argue that the model
will be a useful tool both for investigators interested in basic
papillomavirus biology and for those wishing to test hypotheses
of synonymous codon usage.
To carry out this work, we generated a panel of papillomavirus
genomes with different numbers of synonymous codon ‘‘optimi-
zations’’ in the oncogenes E6 and E7 and tested them in our rabbit
model (Cladel et al., 2008a). We followed the papillomas over
time for many months and observed altered growth rates relative
to wild type, increased immunogenicity, as detected by complete
or partial regressions, and, most strikingly, shortened times to
and increasing numbers of cancers. These data afﬁrmed the
growing recognition that synonymous codons are not silent
(Sauna and Kimchi-Sarfaty, 2011; Venetianer, 2012; Katsnelson,
2011; Edwards et al., 2012; Chen et al., 2010).
We isolated the RNA from lesions in an experiment especially
designed to compare RNAs generated from wild type and two
codon-modiﬁed genomes. The animals were sacriﬁced at week
8.5, a time point at which the papillomas have reached a
signiﬁcant size but have not yet progressed to cancer. Interest-
ingly, we did not see differences between wild type and codon-
modiﬁed E6 or E7 mRNA levels. This ﬁnding was in contrast to our
earlier in vitro studies that showed large increases in message
with changes in codon usage (Cladel et al., 2008b) and demon-
strates the importance of an in vivo model to elucidate biologi-
cally meaningful outcomes.
Using an in vitro analysis, we showed in our earlier study, that
codon-optimized E7 RNAs were more stable than wild type RNA.
There are a very few assays to test RNA stability in vivo and they
have been developed for speciﬁc circumstances (Hilgers et al.,
2005; Lee et al., 1998); we have not developed such an assay for
the CRPV viral oncogene RNAs. Therefore, we used the Zuker M-
Fold program, version 3.5, (Zuker, 2003) to check predicted
stabilities of wild type and codon-modiﬁed genes, both E6 and
E7. mRNAs from all codon-modiﬁed genes were predicted to be
more stable than wild type with the exception of E7/18, which
showed little change. We hypothesize that the codon changes
may have conferred enhanced stability in vivo while at the same
time inﬂuencing degradation such that steady state levels of
mRNA did not appear to change (as observed in our Q RTPCR
studies). For a review of mRNA stability and degradation, see
Knapinska et al. (2005). It remains unclear how these factors
would come together to affect the translation of the oncogenes.
Increased stability of mRNA is one mechanism that might be
associated with more oncoprotein, as noted above. It is also
possible that the codon changes may have inﬂuenced translation
rate (Gingold and Pilpel, 2011) which, in turn, might have led to
more properly folded protein. Synonymous codon usage has been
associated with altered protein folding in numerous recent
studies (Drummond and Wilke, 2008; Warnecke and Hurst,
2010; Zhou et al., 2009).We analyzed E7 protein content using an in-house developed
monoclonal antibody. Since we were looking for quantitative
differences in protein production and since these differences were
likely to be small, we chose to examine the E7 protein in
histological sections rather than in papilloma homogenates. We
found that the oncogene localized to the nucleus but we were not
able to convincingly quantitate differences in E7 protein between
the wild type and codon-optimized papillomas.
Our data show that cancers are much more common in the
codon-optimized lesions and we hypothesized that proliferation
markers would be more pronounced in these lesions. MCM7
staining was stronger in papillomas generated by codon-
modiﬁed genome E7/14-E6/15 at the early time point but not at
later time points. PHH3 positivity was less in papillomas from this
genome for both time points 3 and 4. We know that cancer and
the processes associated with its inception and progression are
highly complex phenomena that are inﬂuenced by multiple
factors. In a recent review (Hanahan and Weinberg, 2011), the
authors note that excessive proliferation can trigger cellular
senescence with resultant loss of proliferation markers. Even-
tually, selected cells may adapt to the stresses they are experien-
cing and proceed to renewed proliferation. These cells will have a
competitive advantage and may progress to malignancy. Support
for this sequence of events in breast cancer was recently pub-
lished (Jerby et al., 2012). Corroborating work on melanoma has
also been reported (Hoek et al., 2008). Davy and Doorbar (2007) in
a review report G2/M arrest induced by E6 and E7 expressions in
papillomavirus infections. We hypothesize that in the experi-
ments reported here, time point 4 represents a period during
which the cells are accommodating to the abundant stresses
induced by earlier proliferation and that this leads to G2/M arrest
and accounts for the reduction in proliferative signal seen with
both MCM7 and PHH3 biomarkers. This period of relative senes-
cence appears to be reached more quickly by the papillomas from
codon-modiﬁed genomes.
We examined viral DNA copy number in our lesions and found
statistically higher copy numbers of DNA in papillomas from
codon-modiﬁed genomes relative to wild type. Davy and Doorbar
in their review, note that papillomaviruses are able to initiate a
pseudo S phase to increase viral DNA synthesis following G2/M
arrest.
Codon-modiﬁed papillomas showed a greater tendency for
regression or reduced growth in this study. We have published
several studies on regression rates of rabbit papillomas in the past
(Hu et al., 2002; Wilgenburg et al., 2005; Okabayashi et al., 1993)
and have shown that the process is associated with the inﬁltration
of lymphocytes. Similar observations were also shown by
Selvakumar et al. (1997). For a review of the immunology of
papillomaviruses see (Nicholls and Stanley, 2000). The wild type
strain of CRPV in regular use in our laboratory rarely results in
regressions. We hypothesize that the regression seen in papillomas
initiated by codon-optimized DNAs is triggered by larger amounts of
oncoproteins being produced in the lesions and subsequently
targeted by the immune system. The genome that exhibited the
greatest tendency to regression was the one we tested with the
greatest number of codon-modiﬁcations, E7/22-E6/17. The differ-
ential response of the 11 animals in this experiment was undoubt-
edly due to the MHC differences in the outbred animals, differences
that are not grossly obvious with wild type CRPV. Note that very
early cancers were seen in some of the progressing lesions from this
genome. This evidence supports the concept of an interplay between
malignant progression and immunological response. Grivennikov
et al. (2010) in a recent review on the connections between
immunity, inﬂammation and cancer note that an in vivo model to
study the inﬂuences of immunity and inﬂammation on cancer
development is needed. Our model could serve this function.
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showed more abnormal pathology in the papillomas from codon-
modiﬁed genomes at a given time point. Fig. 10A–C is representative.
Many of these sections showed high levels of lymphocytic inﬁltrates.
Grivennikov et al. (2010) note that inﬂammation always accompa-
nies cancer and that both tumor promoting inﬂammation and tumor
controlling immunosurveillance can occur in the same lesion. This
observation can help to explain the regressions and reductions in
growth observed in this study as well as the behavior of the two
papillomas that regressed and then returned to quickly become
malignant.
The CRPV/rabbit model has considerable potential for the
study of the signiﬁcance of synonymous codon usage. The library
of codon-modiﬁed CRPV genomes that we have created repre-
sents a small subset of the potential genomes possible. By altering
the codons in targeted ways, it will be possible to test in vivo the
observations accruing from in silico analyses. There are few other
models available to conduct such studies. Carlini et al. success-
fully deoptimized leucines in the alcohol dehydrogenase (Adh)
gene of Drosophila and showed decreasing enzymatic function
with increasing numbers of altered codons. They concluded that
the reduction in function was due to reduced translation of the
protein and that each deoptimized codon contributed to 2.13%
decline in protein production as measured by reduction in
enzymatic activity (Carlini, 2004). Recent work from the same
group has shown that ‘‘optimizations’’ of the same leucines
resulted in increased enzymatic activity in larvae but not in adult
ﬂies (Hense et al., 2010). This study thus links stage of develop-
ment as well as alterations in translation with codon usage.
Several studies have investigated synonymous codon changes in
the capsid protein of poliovirus. For example, Mueller et al. (2006)
showed that codon deoptimization resulted in greatly attenuated
virus and that the attenuation could be attributed to a modest
reduction in rate of translation. This paper demonstrated that
profound phenotypic differences could result from small changes
in protein production. The work of Mueller et al. was followed by
a study by Coleman et al. (2008) in the same laboratory. In this
case, synonymous changes were made to codon pairs and similar
observations were reported. A recent report from another labora-
tory in which CpG and TpA dinucleotides were increased in the
capsid coding region also demonstrated viral attenuation with
only a modest reduction in translation (Burns et al., 2006).
The CRPV/rabbit model has distinct advantages to study the
impact of synonymous codon changes in situ. The data presented
in this paper demonstrate its utility. Among the attributes of our
model that make it especially attractive for these studies are the
following:1. CRPV DNA is infectious. Modiﬁcations can be made to the
small (about 8 Kb) genome by common laboratory techniques
and quickly tested in our well-established infection assay
(Cladel et al., 2008a).2. Because the genome is small, more extensive modiﬁcations
can be made by direct synthesis of the codon-modiﬁed
genome or part thereof.3. Since this project was initiated, the rabbit genome has been
sequenced (NCBI, Oryctolagus cuniculua, bio project
PRJNA42933, PRJNA12819) and signiﬁcant numbers of
reagents are now available to investigators. The rabbit genome
is closer to that of the human than that of the mouse and many
antibodies raised to human proteins cross-react with rabbit
counterparts. We have made use of a number of these reagents
in this study.4. The CRPV genome demonstrates considerable plasticity as
evidenced by work in our laboratory (Hu et al., 2006). Thusit can be expected to tolerate a wide range of synonymous
codon changes as, indeed, we have shown with the genomes
generated for this study. Phenotypic changes in outcome will
help in the evaluation of the signiﬁcance of the codon changes.
Measurements as basic as size of the papillomas relative to
those generated by wild type DNA will reveal much about the
signiﬁcance of the changes made.5. The rabbit is a mammal with an immune system similar to
that of humans and a propensity for some of the same types of
infections. In this paper we have shown that codon changes in
the CRPV oncogenes can inﬂuence both immunogenicity and
oncogenicity of the virus. These observations pave the way for
the study of the interplay between the two in a mammalian
system akin to that of the human. To our knowledge, there is
no better model available.6. To date we have made selective changes to the E6 and E7
genes. However, changes to the other CRPV genes could also be
revealing from both virological and codon usage perspectives.
That is to say, basic properties of codon usage can be studied in
this system and, as they are revealed, can be expected to shed
light on properties of the virus itself. It is helpful that codon
usage of the virus is very different from that of the host. This
will allow for a wide latitude of changes. The need for a system
that can couple the investigation of theories of codon usage
with a model that provides a biologically meaningful readout
has been articulated in the review of Plotkin and Kudla (2011).
The CRPV/rabbit model could serve this function well.Materials and methods
Preparation of codon-altered genomes
The Hershey wild type cottontail rabbit papillomavirus (Her-
shey CRPV, wt H. CRPV, Genbank accession number JF303889) was
used as the backbone for all constructs. The genome was cloned
into PUC 19 at Sal1. The EcoR1 site was removed from the vector
and a Cla1 site at 1383 just downstream of the E1 start and a Sac II
site at 174 downstream of the E6 start were introduced into the
CRPV genome by site-directed mutagenesis. Naturally occurring
EcoR1 (1063) was used in conjunction with Cla1 to facilitate E7
replacements and EcoR1 and SacII were used to facilitate E6
replacements. The genome with the engineered SacII and Cla1
restriction sites was wild type in its growth characteristics and has
been used as a backbone in many of our previous studies.
Synonymous codon changes were introduced into E6 and E7
subclones by site-directed mutagenesis using the polymerase Pfu
Turbo (Stratagene, LaJolla, CA) and a modiﬁcation of the company’s
Quick Change protocol as delineated in (Cladel et al., 2008b). All
products were sequenced in the core facility of the PA State
University College of Medicine to verify the changes and to assure
that additional alterations had not been introduced; the genes
were then cloned into the wild type backbone in place of the wild
type genes. Mutations in E6 are shown in Fig. 1. Alterations in
frequency of codon usage that resulted from the modiﬁcations are
shown in Table 4. Mutations in E7 were reported in (Cladel et al.,
2008b) and are also shown in Supplementary Fig. S1.
Codon changes were based on the work of Zhou et al. (1999)
and were done at random with the primary goal of changing a
viral codon rare in mammals to one most common in mammals.
Thus, even though the amino acids were chosen at random, those
that would result in the most signiﬁcant codon change were given
priority. E6/15 changes involved nine different amino acids.
Leucine was most commonly altered both because of its fre-
quency in the 5’ portion of the E6 gene and because the change
Table 5
Comparison of codon usage for mammals human, cow, and rabbit and for CRPV. Recent
data from the Kazusa data base (http://www.kazusa.or.jp/codon/) were used to
compile codon usage for three mammals, human, cow and rabbit, and for CRPV.
Codon usage for the mammals is similar. However, codon usage between rabbit (host)
and CRPVwas computed to be very different for many of the codons. (StatCalc program
(http://www.statpac.com/statistics-calculator/free-version.htm).
Amino Acid Codon Human Cow Rabbit CRPV
Arg CGU 4.5 4.6 3.7 3.3
CGC 10.4 11.1 13.0 8.2
CGA 6.2 6.4 5.0 4.3
CGG 11.4 12.5 11.4 4.3
AGA 12.2 10.7 9.2 25.2
AGG 12.0 11.4 10.6 12.7
Leu UUA 7.7 6.3 5.3 15.6
UUG 12.9 12.0 10.9 16.1
CUU 13.2 11.9 10.1 18.1
CUC 19.6 21.2 23.6 9.4
CUA 7.2 6.1 4.9 16.4
CUG 39.6 43.5 48.9 23.5
Ser UCU 15.2 13.1 10.4 15.1
UCC 17.7 17.3 19.4 8.2
UCA 12.2 9.9 7.7 15.3
UCG 4.4 5.0 5.7 3.7
AGU 12.1 11.0 8.5 17.6
AGC 19.5 19.3 19.3 17.3
Thr ACU 13.1 11.5 9.9 15.3
ACC 18.9 20.1 22.0 8.8
ACA 15.1 13.0 11.7 27.2
ACG 6.1 7.2 9.1 7.6
Pro CCU 17.5 15.8 12.6 16.6
CCC 19.8 20.4 20.8 15.0
CCA 16.9 14.6 11.8 19.2
CCG 6.9 7.8 8.7 13.2
Ala GCU 18.4 17.9 15.5 18.9
GCC 27.7 30.5 34.2 8.9
GCA 15.8 14.3 12.7 25.1
GCG 7.4 8.6 9.5 6.5
Gly GGU 10.8 10.8 8.8 16.7
GGC 22.2 24.4 26.7 10.8
GGA 16.5 16.2 14.7 17.9
GGG 16.5 16.8 17.0 22.5
Val GUU 11.0 10.1 8.7 15.1
GUC 14.5 15.9 18.0 13.5
GUA 7.1 6.3 4.8 9.1
GUG 28.1 30.8 33.3 20.4
Lys AAA 24.4 22.4 20.2 24.3
AAG 31.9 34.7 35.1 23.0
Asn AAU 17.0 14.7 13.4 16.8
AAC 19.1 21.4 24.2 18.7
Gln CAA 12.3 10.5 9.2 19.9
CAG 34.2 35.0 33.0 27.5
His CAU 10.9 9.4 7.3 11.2
CAC 15.1 15.5 16.0 6.9
Glu GAA 29.0 26.9 24.2 34.9
GAG 39.6 41.9 43.7 27.8
Asp GAU 21.8 20.5 17.6 34.3
GAC 25.1 28.2 30.5 28.9
Tyr UAU 12.2 11.4 10.0 22.6
UAC 15.3 17.5 20.0 10.1
Cys UGU 10.6 9.3 8.2 17.9
UGC 12.6 12.6 13.6 19.2
Phe UUU 17.6 16.4 16.4 25.8
UUC 20.3 22.3 28.4 14.5
Ile AUU 16.0 14.6 14.3 15.8
AUC 20.8 23.3 29.7 5.8
AUA 7.5 6.7 6.1 16.3
*Frequency per thousand.
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scenario was also true for E7 (data not shown). Each new
construct contained all of the mutations from the previous one
in addition to the new changes. Thus E7/14 contained all of the
codon changes in E7/8 plus six more. E7/18 contained all of those
in E7/14 plus four more and E7/22 contained all of the changes in
E7/18 plus four additional changes. Since the time that this work
was begun, enhanced sequence information has become available,
including partial data for rabbit. Based on this information (http://
www.kazusa.or.jp/codon/), Table 5 has been constructed showing
relative codon usages for all amino acids for human, cow, rabbit
and CRPV. These data do not differ markedly from the earlier data
used by Zhou et al. (1999) and support our decision to use those
data as a foundation for our work. Chi-square analysis using the
Stat Calc program freely available on the web (http://www.
statpac.com/statistics-calculator/free-version.htm) was used to
compare rabbit and CRPV codon usages and to determine that
they are very different (Po0.0000 for most amino acids).
DNA challenge and monitoring of tumors
The DNA constructs were prepared using the Qiagen maxiprep
system (www.qiagen.com) and were puriﬁed by cesium chloride
density ultracentrifugation and adjusted to 200 mg/ml in 1X TE
buffer for challenge on animals. New Zealand White (NZW)
rabbits were maintained in the animal facility of the Pennsylvania
State University College of Medicine. Most were outbred animals
obtained from Robinson (Mocksville, NC); six were donated
rabbits obtained from Millbrook, MA. The studies were approved
by the Institutional Animal Care and Use Committee of the
Pennsylvania State University (IACUC protocol #5, 97-202). For
application of viral DNA, rabbits were sedated using ketamine/
xylazine anesthesia. Back skin of the animals was scariﬁed with a
scalpel blade to create an abrasion. Three days later, again under
anesthesia, the wounded sites were lightly scratched with a
scalpel blade to introduce nicks into the scabs. Each site was
then challenged with 5 mg DNA in 50 ml of 1 TE buffer and the
DNA was scratched into the wound using a 21 G needle (Cladel
et al., 2008a). Monitoring of papilloma outgrowth began two
weeks after infection and continued until time of sacriﬁce of the
animals. In general, each animal was infected with wild type
H. CRPV DNA at two sites and with experimental genomes at
8 sites for a total of 10 sites, ﬁve on each side of the back. In some
experiments, the experimental genomes were the same and in
others, they were mixed at different sites on the same animal.
This allowed us to compare the behavior of different genomes on
the same animal in some cases as well as to study individual
genomes in isolation in other cases.
Immunohistochemical analysis of tumors
MCM7 (also known as cdc 47) staining was done on parafﬁn
embedded, formalin-ﬁxed tissues using NeoMarkers monoclonal
antibody # MS-862-PO. Citrate buffer antigen retrieval at 90 1C
was used before incubating the tissues at 1:150 dilution of the
primary antibody for 4 h. Slides were thoroughly rinsed in PBS
followed by antibody detection using an HRP polymer conjugate
(Zymed 87–9163) for 45 min. Amino ethyl carbazole (AEC)
chromogen was applied for 20 min and the slides were washed
and mounted in Crystal Mount.
For E7 staining, parafﬁn sections were dewaxed and rehy-
drated in water and washed in PBS. They were treated with 3%
hydrogen peroxide for 6 min and washed well with three changes
of PBS. The sections were incubated for 15 min in 4 mg/ml pepsin
dissolved in 0.1 N HCl at 37–45 1C. They were then washed with
at least three changes of PBS. 3% BSA in PBS was applied for30 min and then drained off without washing. The E7 MAb at
1:100 was applied for 1 h and the slides were then washed with
PBS. Super Picture Polymer Detection Agent (Invitrogen # 87–
9163) was applied for 30 min and the slides were washed well
with PBS. AEC chromogen was applied for 30 min. Slides were
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aqueous media.
For PHH3 staining, ﬁve micron parafﬁn sections were dewaxed
and rehydrated in distilled water. Antigen retrieval was per-
formed using a Citrate Buffer pH 6.0 at 95 1C for 12 min. Slides
were allowed to cool in this solution for 30 min before washing in
PBS. Non-speciﬁc binding was blocked by a 20 min incubation in
3% BSA in PBS. Rabbit anti-human PHH3 (Cell Signaling cat#
9701) was diluted to 1:250 and allowed to incubate at RT for 2 h.
Primary antibody binding was detected using anti-Rabbit perox-
idase conjugated secondary antibody (Vector ImmPRESS cat# MP-
7401) for 40 min. Complexes were visualized with Nova Red
substrate kit (Vector cat# SK4800). Slides were dehydrated
through graded ethanols and coverslipped from xylene in a
permanent mounting medium.
PHH3 quantitation
PHH3 was quantitated by two methods. In the ﬁrst method,
multiple ﬁelds from each section were scanned under a Nikon
Eclipse (E600) microscope and the positive cells were counted
and average total counts per 20 ﬁeld were calculated (Coupland
et al., 2008). Data for each animal were compared using the
Mann–Whitney Rank Sum Test for uneven distributions.
In the second method, the ‘‘hot spots’’ and the ﬁelds adjacent
to them were quantitated as per the protocol of Perry et al.
(1997). The Student’s t test was used to compare counts for wild
type and codon-modiﬁed papillomas.
Statistics
Papilloma size was determined by calculating the cubic root of
the product of lengthwidthheight of individual papillomas in
millimeters to obtain a geometric mean diameter (GMD). Data
were represented as the means (þSEMs) of the GMDs for each
test group. The signiﬁcance of percentage of cancer sites/tumor
sites induced by different constructs was determined by the
Fisher’s exact test (Po0.05 was considered signiﬁcant). Student’s
t test was used to determine signiﬁcance of Q RTPCR and Q PCR
results.
Fisher’s exact test was used to determine signiﬁcance of the
cancer and regression data.
Quantitative RTPCR analysis of total RNA isolated from papillomas
RNAs were isolated from ﬂash frozen papilloma tissue using the
TRIzol reagent (www.Invitrogen.com). 10 mg RNA was treated with
Turbo DNA-free (product # AM 1907, www.invitrogen.com) to
remove any contaminating DNA. RNAs were retrieved in a standard
volume of 50 mm. Reverse transcription and quantitative PCR were
performed on 200 ng of the RNA using Stratagene’s Brilliant II QRT-
PCR one-step kit (# 600809). RNAs used in the study had 260/280
ratios of 1.9–2.0 as well as intact ribosomal bands as determined by
agarose gel electrophoresis. Primers and probe were designed using
Primer Express software&. TATA-binding protein (TBP) amplicons,
internal standards for the analyses, were generated using primers 50
CACGGCACTGATTTTCAGTTCT 30 (nt 627–648) and 50TTCTTGCT-
GCCAGTCTGGACT 30 (nt706-686) and used at ﬁnal concentrations
of 200 nM. Probe for TBP was ﬂuorogenic TaqMan probe 50HEX
TGTGCACAGGAGCCAAGAGTGAAGA BHQ-1 30 and was used at a ﬁnal
concentration of 100 nM. CRPV E7/14, 18 and 22 primers were
50AAGCGCTGTAGGCAGACCA 30 (16–35) and 50TCGATTCAAGGTTCTG-
ATGGC 30 (84–105) and were used at a ﬁnal concentration of
300 nM. Probe was ﬂurogenic TaqMan probe 50FAM CAGCTTCGT-
CTGCGTCTGTGATCCA-BHQ-1 30 (36–61) and was used at a ﬁnal
concentration of 100 nM. Wild type CRPV E7 primers were 50CCATGTAAGCGCTGTAGGCAAA 30 (10–32) and 50GCAGTCGATTCA
AGGTTCTTATGGC 30 (85–109) and were used at a ﬁnal concentration
of 300 nM. Probe was 50FAM TCAGCTTCGTCTGCGTCTGTGATCC BHQ-
1 30 (35–60) and was used at a ﬁnal concentration of 100 nM. E6
primers for all genomes were 50 GGGTCATTGCAGTTCTTG 30 (233–
250) and 50 GGACGCAACACTCGTCACAT 30 (314–333). These were
used at a ﬁnal concentration of 300 nM. E6 probe was ﬂurogenic
TaqMan probe 50FAM TCCCGGCAGTCGCTGCGG-BHQ -1 30 used at a
concentration of 100 nM. Primers and probes for the E6 and E7 genes
were synthesized by Biosearch Technologies (www.biosearchtech.
com). Primers and probes were optimized prior to the running of E6/
E7 analyses. A standard curve was run on each plate using 1:2
dilutions of one of the samples. This enabled efﬁciencies to be
determined. All qRT-PCR reactions were performed using the Mx-
3005 P instrument (Agilent Technologies). Cycling conditions were
50 1C for 30 min (reverse transcription) followed by 42 cycles of 94 1C
for 15 s and 60 1C for 1 min. Analysis was done using the delta delta
Ct method (Pfafﬂ, 2001). Student’s t test was used to determine
signiﬁcance.
Compilation of cancer data
The data in this study were collected over a period of several
years. All animals in use in our laboratory and infected with wild
type and/or codon-modiﬁed genomes were carefully monitored
for papilloma growth and cancer development. Data were pooled
to generate the cancer information. Cancer was ﬁrst detected
visually and then conﬁrmed histologically.
Compilation of regression data
The data in this study were collected over a period of several
years. All animals in use in our laboratory and infected with wild type
and/or codon-modiﬁed genomes were carefully monitored for papil-
loma growth. In those cases in which papillomas regressed or
partially regressed, notations weremade in the charts and regressions
were followed. Data were pooled to generate the regression data.
Detection of E6 and E7 sequences in papilloma DNA
DNAs were isolated from tissues using the Qiagen DNeasy system
(product # 69506, www.qiagen.com). E6 and E7 genes were ampliﬁed
by PCR and the products were sequenced in the core facility at the
Pennsylvania State University College of Medicine.
Determination of relative copy numbers of viral DNA in papillomas
DNA was isolated from papilloma fragments using the DNeasy
kit (www.Qiagen.com) and quantitated spectrophotometrically.
200 ng was subjected to quantitative PCR using the Sybr green kit
#600828 from Agilent Technologies. For the ampliﬁcation of a
portion of CRPV E6, primers (50GGA CGC AAC ACT CGT CAC AT)
and (50 GGG TCA TTG CAG TTC TTG CA) were used. As an internal
control, 18 S RNA was ampliﬁed in separate reactions on the same
plate using primers (50 CGC CGC TAG AGG TGA AAT TC) and
(50TTG GCA AAT GCT TTC GCT C). Primers were used at 300 nM
concentrations in each case after optimization of conditions.
Standard curves were run on each plate for both E6 and 18S
DNAs. Efﬁciencies were in the range of 90–110%.
The differences between the Cts for E6 for a given sample and
18S for the same sample were used to determine relative
differences in DNA concentration. Each delta Ct represents a
two-fold difference in concentration. Delta Cts for both wild type
and codon-modiﬁed DNAs were entered into SigmaPlot version
11.0 and Student’s t test was used to analyze results.
N.M. Cladel et al. / Virology 438 (2013) 70–8382Analysis of RNA stabilities by M-fold
Each wild type and codon-modiﬁed E6 and E7 gene was folded
using the Zuker M-fold program (version 3.5) freely available on
the web (http://www.bioinfo.rpi.edu/applications/mfold). The
program yields a number of possible folds listed in order of most
stable (lowest free energy) to least stable. The most stable fold
was chosen for each sequence. Results are shown in Table 2.Acknowledgments
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